Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Loganin Modulates Inflammatory Signalling and Epidermal Alterations in an Imiquimod-Induced Psoriasis Mouse Model.

Created on 10 Nov 2026

Authors

Eda Acikgoz, Cafer Tas, Mustafa Cakir, Seda Keskin

Published in

Journal of biochemical and molecular toxicology. Volume 40. Issue 11.

Abstract

Psoriasis is a chronic immune-mediated inflammatory skin disease driven by abnormal interactions among keratinocytes, immune cells and cytokine networks. Dysregulated inflammatory signalling has been shown to exacerbate psoriatic inflammation. Loganin (LOG), a natural iridoid glycoside, exhibits anti-inflammatory effects in experimental models, yet its relevance to psoriasis remains poorly characterised. This study investigated the effects of LOG during the development of IMQ-induced psoriasis-like inflammation, evaluating its influence on inflammatory signalling and associated tissue responses using PASI scoring, histopathology and stereology. Molecular and cellular alterations were assessed using qPCR, immunohistochemistry, immunofluorescence, and ELISA to determine changes in pro-inflammatory cytokine profiles, NOD-like receptor protein 3 (NLRP3) inflammasome components, markers of epidermal proliferation and keratinocyte remodelling, and vascular responses. Topical IMQ induced characteristic psoriatic alterations, including epidermal hyperplasia, immune cell infiltration, microvascular activation, and elevated pro-inflammatory cytokines. LOG significantly attenuated IMQ-associated body weight loss, reduced psoriatic clinical severity scores and epidermal thickening, and decreased proliferating cell nuclear antigen (PCNA) and cytokeratin-17 (CK-17) immunoreactivity. Furthermore, LOG attenuated vascular endothelial growth factor receptor-2 (VEGFR2) immunoreactivity and decreased interleukin-17A (IL-17A) and interleukin-1β (IL-1β) levels, suggesting modulation of inflammatory and vascular responses. LOG also downregulated the expression of NLRP3, apoptosis-associated speck-like protein (ASC), and caspase-1. Collectively, these findings indicate that LOG attenuates IMQ-induced inflammatory responses and is associated with reduced expression of NLRP3 inflammasome-related components. These findings support the anti-inflammatory effects of LOG in the IMQ-induced psoriasis model while indicating that further functional studies are required to determine whether LOG directly affects NLRP3 inflammasome activation.

PMID:
43006302
Bibliographic data and abstract were imported from PubMed on 10 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 10
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement